Cited by 275Cardiac Ischemia and ReperfusionCardiac Fibrosis and RemodelingCell death mechanisms and regulation

Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart

Open access
Oshima, Yuichi, Ouchi, Noriyuki, Sato, Kaori, Izumiya, Yasuhiro, Pimentel, David R., Walsh, Kenneth·2008·Circulation

Abstract

BACKGROUND: The Akt protein kinase is an important mediator of cardiac myocyte growth and survival. To identify factors with novel therapeutic applications in cardiac diseases, we focused on the identification of factors secreted from Akt1-activated cells that have cardioprotective effects through autocrine/paracrine mechanisms. METHODS AND RESULTS: Using an inducible Akt1 transgenic mouse model, we have found that follistatin-like 1 (Fstl1) protein and transcript expression are increased 4.0- and 2.0-fold, respectively, by Akt activation in the heart (P<0.05). Fstl1 transcript was also upregulated in response to myocardial stresses including transverse aortic constriction, ischemia/reperfusion injury, and myocardial infarction. Adenovirus-mediated overexpression of Fstl1 protected cultured neonatal rat ventricular myocytes from hypoxia/reoxygenation-induced apoptosis (P<0.01), and this protective effect was dependent on the upregulation of both Akt and ERK activities. Conversely, knockdown of Fstl1 in cardiac myocytes decreased basal Akt signaling and increased the frequency of apoptotic death in vitro (P<0.01). The intravenous administration of an adenoviral encoding Fstl1 to mice resulted in a 66.0% reduction in myocardial infarct size after ischemia/reperfusion injury that was accompanied by a 70.9% reduction in apoptosis in the heart (P<0.01). CONCLUSIONS: These results indicate that Fstl1 is a cardiac-secreted factor that functions as an antiapoptotic protein. Fstl1 could play a role in myocardial maintenance and repair in response to harmful stimuli.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.108.767673

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • FSTL1 has cardioprotective effects in animal models of cardiac injury, promoting endothelial cell function and revascularization through a mechanism that includes nitric oxide synthase.

    “FSTL1 has been shown to possess cardioprotective effects, promoting endothelial cell function and thereby revascularization in animal models of cardiac injury through a mechanism that includes nitric oxide synthase (194, 195).”

    From Muscle–Organ Crosstalk: The Emerging Roles of Myokines (2020) · cites this paper as [195]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Oshima, Y., Ouchi, N., Sato, K., Izumiya, Y., Pimentel, D. R., & Walsh, K.
Affiliations
Boston University (US)
Venue
Circulation
Published
2008-06-17
Volume
117
Issue
24
Pages
3099-3108
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2121202595
Cited by
275
References
43
Citations by year
2026: 8 · 2025: 23 · 2024: 12 · 2023: 9 · 2022: 20 · 2021: 15 · 2020: 28 · 2019: 18 · 2018: 13 · 2017: 18 · 2016: 21 · 2015: 15 · 2014: 15 · 2013: 11 · 2012: 11
FWCI
8.99
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Aging (R01AG015052, R37AG015052, AG15052)
  • National Heart, Lung, and Blood Institute (HL81587, HL77774, R01HL086785, HL71563, R01HL116591, P01HL081587, HL 86785, R01HL077774, K08HL071563)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
FSTL1, Akt signaling, cardioprotection, myocardial infarction, ischemia-reperfusion injury, apoptosis, ERK signaling, autocrine and paracrine signaling, ventricular myocytes, transverse aortic constriction, adenoviral gene transfer
MeSH terms
Animals, Cardiotonic Agents, Cloning, Molecular, Gene Expression Regulation, Heart, Humans, Major Histocompatibility Complex, Mice, Transgenic, Transcription, Genetic, Reperfusion Injury, Up-Regulation, DNA, Complementary, Oligonucleotide Array Sequence Analysis, Myocytes, Cardiac, RNA, Small Interfering, Follistatin-Related Proteins, Proto-Oncogene Proteins c-akt, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review